Plasma MIP-1beta levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib (Q46695473)
scientific article
Language:
(P31) (Q13442814)
(P304) 393-399
(P433) 3
(P478) 50
(P577) Thursday, September 8, 2005
(P1433) (Q641464)
(P1476) "Plasma MIP-1beta levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib" (language: en)
(P2093) Hideharu Kimura
Kazuo Kasahara
Masaru Sekijima
Tomohide Tamura
Kazuto Nishio
other details
description scientific article

External Links